Target intelligence / Profile preview

Eukaryotic translation initiation factor 2-alpha kinase 3 (PERK) (PERK)

Target
PERK
Molecular classification
Enzyme, Serine/threonine protein kinase, Receptor-like kinase, Chaperone (GRP78 component)
01

Overview

The GRP78-PERK pathway is a fundamental branch of the Unfolded Protein Response (UPR) that monitors and responds to endoplasmic reticulum (ER) stress. Under homeostatic conditions, the ER chaperone GRP78 (also known as BiP) remains bound to the luminal domain of the sensor kinase PERK (Eukaryotic translation initiation factor 2-alpha kinase 3), maintaining it in an inactive monomeric state (UniProt: P11021). Upon the accumulation of unfolded proteins, GRP78 dissociates from PERK to assist in protein folding, which triggers PERK dimerization and autophosphorylation. Activated PERK then phosphorylates the alpha subunit of eukaryotic initiation factor 2 (eIF2-alpha), causing a global inhibition of protein translation to reduce the ER workload while selectively promoting the translation of stress-adaptive genes such as ATF4 (UniProt: Q9NZJ5; PubMed: 32051602). This pathway is a major therapeutic target in oncology and neurology. Cancer cells often hijack the GRP78-PERK axis to survive the proteotoxic stress of hypoxic and nutrient-poor microenvironments, making PERK inhibition a strategy to selectively trigger apoptosis in tumors (PubMed: 23676665). Conversely, chronic activation of this pathway in neurodegenerative diseases like Alzheimer's and Parkinson's contributes to synaptic loss through prolonged translation attenuation. Despite its promise, systemic inhibition of PERK poses significant safety challenges, notably pancreatic toxicity and hyperglycemia, as PERK is essential for the health of insulin-secreting beta cells (PubMed: 23056100). Consequently, drug development has expanded to include downstream modulators like the integrated stress response inhibitor ISRIB, which may offer a wider therapeutic window.

Other names
GRP78-PERK pathwayEIF2AK3Protein kinase RNA-like endoplasmic reticulum kinasePRKR-like endoplasmic reticulum kinase78 kDa glucose-regulated protein (GRP78)Binding immunoglobulin protein (BiP)HSPA5-EIF2AK3 axis
02

Mechanism of action

Small molecule inhibition of the PERK kinase catalytic domain prevents the phosphorylation of eIF2-alpha, thereby blocking the integrated stress response and sensitizing stressed cells to apoptosis.

03

Biological functions

Signal transductionUnfolded protein responseApoptosisTranslation regulationCell cycle arrestProtein folding
04

Disease associations

CancerNeurodegenerative diseaseDiabetes mellitusWolcott-Rallison syndromeIschemia
05

Safety considerations

Pancreatic exocrine and endocrine toxicitySevere hyperglycemiaPancreatic atrophyDisruption of proteostasis in secretory tissuesWolcott-Rallison-like syndrome
06

Interacting drugs

GSK2606414

6 more in the full profile.

07

Biomarkers

Phospho-eIF2-alpha (p-eIF2a)Activating transcription factor 4 (ATF4)C/EBP homologous protein (CHOP)Glucose-regulated protein 78 (GRP78/HSPA5)

Beyond the preview

Go deeper on Eukaryotic translation initiation factor 2-alpha kinase 3 (PERK) (PERK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation initiation factor 2-alpha kinase 3 (PERK) (PERK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call